Can surveying practitioners about their practices help identify priority clinical practice guideline topics?

BMC Health Services Research

Volumn 3, Issue , 2003, Pages 1-5

  Brouwers, Melissa C ^a   Chambers, Alexandra ^a   Perry, James ^b  

^a CANCER CARE ONTARIO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

CANADA; CONTROLLED STUDY; DRUG UTILIZATION; GENERAL PRACTITIONER; GLIOBLASTOMA; GOOD CLINICAL PRACTICE; HUMAN; NORMAL HUMAN; PHYSICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PROPHYLAXIS; QUESTIONNAIRE; REVIEW; SEIZURE; BRAIN NEOPLASMS; CANCER CENTER; CHEMOPROPHYLAXIS; CLINICAL PRACTICE; COMMUNITY HOSPITAL; COMPLICATION; GLIOMA; HEALTH CARE SURVEY; HEALTH PERSONNEL ATTITUDE; MEDICINE; PRIVATE PRACTICE; SEIZURES; SPECIALIZATION; STANDARDS; STATISTICS AND NUMERICAL DATA;

ANTICONVULSANTS; ATTITUDE OF HEALTH PERSONNEL; BRAIN NEOPLASMS; CANCER CARE FACILITIES; CHEMOPREVENTION; DRUG UTILIZATION; GLIOMA; HEALTH CARE SURVEYS; HOSPITALS, COMMUNITY; HUMANS; MEDICINE; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIVATE PRACTICE; SEIZURES; SPECIALIZATION;

EID: 85044699783     PISSN: 14726963     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6963-3-1     Document Type: Review

References (11)

1. Medicine Institute of: Clinical Practice Guidelines: Directions for a New Program. Edited by: FieldMJ and LohrKN. Washington, D.C., National Academy Press; 1990:38.
2. Pater JL, Browman GP, Brouwers MC, Nefsky MF, Evans WK, Cowan DH: Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle. J Clin Oncol 2001, 19:3392-3396.
3. Browman GP, Levine MN, Mohide EA, Hayward RS, Pritchard KI, Gafni A, Laupacis A: The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995, 13:502-512.
4. U.S.Congress Office Technology Assessment: Identifying health technologies that work: Searching for evidence. Volume OTA-H-608. Edited by: USGovernment Printing Office. Washington, DC; 1994.
5. Browman GP, Newman TE, Mohide EA, Graham ID, Levine MN, Pritchard KI, Evans WK, Maroun JA, Hodson DI, Carey MS, Cowan DH: Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. J Clin Oncol 1998, 16:1226-1231.
6. Dillman DA: Mail and internet surveys: the tailored design method New York, John Wiley; 2000.
7. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG: Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurol 2000, 54:1886-1893.
8. Agbi CB, Bernstein M: Seizure prophylaxis for brain tumour patients. Brief review and guide for family physicians. Can Fam Physician 1993, 39:1153-1156.
9. Eccles M, Ford GA, Duggan S, Steen N: Are postal questionnaire surveys of reported activity valid? An exploration using general practitioner management of hypertension in older people. Br J Gen Pract 1999, 49:35-38.
10. Adams AS, Soumerai SB, Lomas J, Ross-Degnan D: Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999, 11:187-192.
11. Council National Health and Medical Research: A guide to the development, implementation and evaluation of clinical practice guidelines. Edited by: AusInfo. Australia; 1999.